AGER and pulmonary fibrosis: However, an acceleration of these compounds occurs in oxidative conditions (typical of the inflammation), and their accumulation contributes to the progression of several chronic diseases (i.e., hepatic fibrosis, lung fibrosis, chronic rhinosinusitis, and pelvic organ prolapse), mainly through the activation of the receptor RAGE.